Allergan (a subsidiary of AbbVie Inc.), Galderma and Merz Pharma are Dominating in the Global Non-Surgical Procedures Market in 2020

Global Non-Surgical Procedures Market is expected to grow with the CAGR of 7.7% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below:

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-non-surgical-procedures-market

Global non-surgical procedures market is a fragmented market which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.   

The major players dealing in global non-surgical procedures market are introducing strong range of non-surgical procedures’ products provider along with launching new non-surgical procedures’ products and adopting strategic initiatives such as acquisition, agreement, business expansion, award and recognition into the market. This helped companies to maximize the sales with enhanced product portfolio. For instance, in October 2017, Merz Pharma has announced the partnership with Teijin. The primary purpose of this partnership is to bring xeomin (incobotulinumtoxinA) to Japan market. This partnership has helped to enhance geographical presence of the company.

Allergan (a subsidiary of AbbVie Inc.) is the dominating player in global non-surgical procedures market. The other key players existing in the non-surgical procedures market are Bioha Laboratories, Bohus BioTech AB, Contura Ltd., Laboratoires VIVACY, Merz Pharma, Prollenium Medical Technologies, Zhejiang Jingjia Medical Technology Co., LTD, Luminera, Medytox, ADODERM GmbH, Azul Skin Health, Bioxis pharmaceuticals, Croma Deutschland GmbH, Sinclair Pharma, Suneva Medical, dr. brandt skincare, DRMTLGY LLC, Galderma, Johnson & Johnson Services, Inc., Krasr, Mary Kay Inc., Rodan & Fields, Teoxane SA, Dermaroller GmbH, Alma Lasers, BIOPLUS CO., LTD., BISON MEDICAL, CHUNGWOO Medical Co., Ltd., Fotona, HUMEDIX.CO.LTD, Weyergans High Care AG and SCULPT Luxury Dermal Fillers LTD among others.

 Non-surgical Procedures MarketAllergan (a subsidiary of AbbVie Inc.):

Allergan (a subsidiary of AbbVie Inc.) is headquartered in Dublin, Ireland. The company is focusing on research and development, exclusively in central nervous system, gastroenterology and medical-aesthetic therapeutic area. The company has wide range of products under categories such as central nervous system, eye care, gastroenterology and medical-aesthetic in which medical-aesthetic is the market focused category.

For instance,

  • In October 2020, Allergan (a subsidiary of AbbVie Inc.) has announced that it has agreed with Luminera which is a privately held aesthetics company with a portfolio and pipeline of dermal filler products. It is estimated that this acquisition anticipated strengthening footprints in the Israel market.

The company has wide presence across Asia-Pacific, Europe, Middle East and Africa and North America.

Galderma:

Galderma is headquartered in Switzerland, Europe and was founded in 1981. The company is focusing on broad range of skin health needs, moreover, the company offer a range of leading medical and consumer skin health brands. The company has products under categories which are for acne, aesthetics, consumer care, onychomycosis, prescription, rosacea, skin cancer and skin care in which aesthetics is the market focused category.

For instance,

  • In November 2020, Galderma launched Dysport in China for treatment of glabellar lines. It is predicted that this product launch has anticipated enhancing the business growth as well as strengthening the footprints in China market.

The company has presence across Europe, North America, Asia-Pacific and Middle East and Africa.

Merz Pharma:

Merz Pharma is headquartered in Frankfurt, Germany and was founded in 1908. The company is focusing on the areas of medical aesthetics and neurotoxin therapy, supported by a number of regional brands in both the prescription medicine and consumer health and beauty sectors. The company has various products under categories that are aesthetics, therapeutics and consumer care in which aesthetics is the market focused category.

For instance,

  • In April 2019, Merz Pharma announced the product launch of New Belotero Revive Dermal Filler. This product works beneath the skin to improve skin hydration, reduce redness and roughness and minimize the appearance of fine lines. This product launch has helped to enhance revenue growth of the company.

The company has presence in Asia-Pacific, Europe, Middle East, North America and South America. The company also has various subsidiary companies such as Merz Asia-Pacific Pte. Ltd (Singapore), Anteis SA (Switzerland), Merz Argentina S.A. (Argentinia) and Merz Middle-East FZ-LLC (Dubai) among others.